Home Dermatology PDF: Update on Drugs & Devices: September-October 2024
- You cannot add another "PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma" to your cart. View cart
Article
PDF: Update on Drugs & Devices: September-October 2024
$1.99
PDF Download: Update on Nemolizumab-ilto SC injection (Nemluvio®), Denileukin diftitox-cxdl IV use (Lymphir™), Deuruxolitinib phosphate tablets (Leqselvi™), Roflumilast cream (Zoryve™), Ustekinumab-ttwe SC/IV injectio (Pyzchiva®), Sofpironium gel, 12.45% (Sofdra™), Ustekinumab biosimilar (Steqeyma® SC/IV injection) and Lebrikizumab SC injection (Ebglyss™).
Read online:
Update on Drugs & Devices: September-October 2024
Related products
-
Article
PDF: Hydrogen Peroxide Topical Solution, 40% for the Treatment of Seborrheic Keratoses
$1.99 Add to cart -
Article
PDF: Real-World Efficacy of Azelaic Acid 15% Gel for the Reduction of Inflammatory Lesions of Rosacea
$1.99 Add to cart -
Article
PDF: Non-Invasive Gene Expression Testing to Rule Out Melanoma
$1.99 Add to cart -
Article
PDF: Update on Drugs & Devices: September – October 2019
$1.99 Add to cart
